Corbus Pharmaceuticals Holdings (CRBP) Enterprise Value (2013 - 2025)

Corbus Pharmaceuticals Holdings' Enterprise Value history runs 13 years deep, the most recent figure standing at -$27.8 million for Q4 2025.

• In Q4 2025, Enterprise Value rose 80.69% year-over-year to -$27.8 million; the TTM figure through Dec 2025 stood at -$27.8 million (up 80.69% YoY), while the FY2025 annual figure was -$27.8 million, up 80.69% from the prior year.
• Enterprise Value was -$27.8 million for Q4 2025 at Corbus Pharmaceuticals Holdings, down from -$25.8 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$3.7 million in Q1 2021 to a low of -$144.0 million in Q4 2024.
• Historically, Enterprise Value has averaged -$49.7 million across 5 years, with a median of -$31.3 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Enterprise Value soared 95.6% in 2022, then plunged 1356.61% in 2024.
• A 5-year view of Enterprise Value shows it stood at -$90.9 million in 2021, then jumped by 95.6% to -$4.0 million in 2022, then tumbled by 147.32% to -$9.9 million in 2023, then slumped by 1356.61% to -$144.0 million in 2024, then soared by 80.69% to -$27.8 million in 2025.
• The last three Enterprise Value figures came in at -$27.8 million (Q4 2025), -$25.8 million (Q3 2025), and -$114.3 million (Q2 2025), per Business Quant data.